Clinical trials: Ulcerative Colitis (Part 2 Only)
- Condition Ulcerative Colitis (Part 2 Only)
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Crohn's Disease, Ulcerative Colitis (Part 2 Only)
A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis
Phase 1 randomized, open-label, multicenter, parallel-group study designed to evaluate efficacy, pharmacokinetics and safety between CT-P13 subcutaneous (SC) and CT-P13 intravenous (IV) in patients with active Crohn's Disease…
- Trial name
- NCT02883452
- Testing
- CT-P13
- Where
- South Korea
- Volunteers
- 181 people
- Sponsor
- Celltrion